Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Genitourinary Cancers
•
General Radiation Oncology
How long after administration would you wait to proceed with an orthopedic surgery to a bone?
Both from radiation safety and clinical toxicity standpoints. Assuming a nonemergent surgery.
Related Questions
When do you consider elective pelvic nodal irradiation for unfavorable intermediate risk prostate cancer?
Is there a benefit in proactively referring patients treated with pelvic radiation to see pelvic rehabilitation in the absence of any symptoms?
Is it safe to administer Lu 177 therapies in patients with epidural disease in the spinal canal?
What vertebral body dose constraint do you use in SBRT to limit compression fracture?
In a patient with very high risk prostate cancer opting for prostatectomy, when, if ever, do you recommend neoadjuvant ADT?
Would you recommend adjuvant radiation for a mucinous urachal adenocarcinoma s/p partial cystectomy and LN sampling with negative margins?
Is there any way to safely treat patients with mCRPC with 177-Lu PSMA who are on hemodialysis?
Would you offer prostate SBRT to a patient who cannot have an MRI?
How do you approach treatment planning for lung SBRT in a patient with a lesion within 1 cm of a defibrillator?
Do you ever initiate on degarelix and then switch to leuprolide for patients with prostate cancer and cardiac risk factors receiving ADT?